184 related articles for article (PubMed ID: 23746695)
21. EGFR inhibitor-mediated apoptosis in solid tumors.
Goel S; Hidalgo M; Perez-Soler R
J Exp Ther Oncol; 2007; 6(4):305-20. PubMed ID: 18038764
[TBL] [Abstract][Full Text] [Related]
22. [Epidermal growth factor receptor and radiotherapy].
Sirák I; Hatlová J; Petera J; Vosmik M; Ryska A; Vosmiková H
Klin Onkol; 2008; 21(6):338-47. PubMed ID: 19382597
[TBL] [Abstract][Full Text] [Related]
23. PHD3 regulates EGFR internalization and signalling in tumours.
Garvalov BK; Foss F; Henze AT; Bethani I; Gräf-Höchst S; Singh D; Filatova A; Dopeso H; Seidel S; Damm M; Acker-Palmer A; Acker T
Nat Commun; 2014 Nov; 5():5577. PubMed ID: 25420589
[TBL] [Abstract][Full Text] [Related]
24. Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis.
Huang SM; Harari PM
Clin Cancer Res; 2000 Jun; 6(6):2166-74. PubMed ID: 10873065
[TBL] [Abstract][Full Text] [Related]
25. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
Nicholl SM; Roztocil E; Davies MG
J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
[TBL] [Abstract][Full Text] [Related]
26. The epidermal growth factor receptor modulates DNA double-strand break repair by regulating non-homologous end-joining.
Kriegs M; Kasten-Pisula U; Rieckmann T; Holst K; Saker J; Dahm-Daphi J; Dikomey E
DNA Repair (Amst); 2010 Aug; 9(8):889-97. PubMed ID: 20615764
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of radiosensitivity in head and neck cancer cells by ZD1839 ('IRESSA'), a selective epidermal growth factor receptor tyrosine kinase inhibitor.
Shintani S; Kiyota A; Mihara M; Sumida T; Kayahara H; Nakashiro K; Hamakawa H
Am J Clin Oncol; 2003 Oct; 26(5):e150-6. PubMed ID: 14528090
[TBL] [Abstract][Full Text] [Related]
28. Combining molecular therapeutics with radiotherapy for head and neck cancer.
Riesterer O; Milas L; Ang KK
J Surg Oncol; 2008 Jun; 97(8):708-11. PubMed ID: 18493923
[TBL] [Abstract][Full Text] [Related]
29. Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells.
Fuchs BC; Fujii T; Dorfman JD; Goodwin JM; Zhu AX; Lanuti M; Tanabe KK
Cancer Res; 2008 Apr; 68(7):2391-9. PubMed ID: 18381447
[TBL] [Abstract][Full Text] [Related]
30. K-RAS(V12) induces autocrine production of EGFR ligands and mediates radioresistance through EGFR-dependent Akt signaling and activation of DNA-PKcs.
Minjgee M; Toulany M; Kehlbach R; Giehl K; Rodemann HP
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1506-14. PubMed ID: 21985943
[TBL] [Abstract][Full Text] [Related]
31. Epidermal growth factor receptor autocrine signaling in RIE-1 cells transformed by the Ras oncogene enhances radiation resistance.
Grana TM; Sartor CI; Cox AD
Cancer Res; 2003 Nov; 63(22):7807-14. PubMed ID: 14633707
[TBL] [Abstract][Full Text] [Related]
32. Rationale and clinical basis for combining gefitinib (IRESSA, ZD1839) with radiation therapy for solid tumors.
Ochs JS
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):941-9. PubMed ID: 14967454
[TBL] [Abstract][Full Text] [Related]
33. Molecular targeting in radiotherapy: epidermal growth factor receptor.
Chung TD; Broaddus WC
Mol Interv; 2005 Feb; 5(1):15-9. PubMed ID: 15731501
[TBL] [Abstract][Full Text] [Related]
34. EGFR status and EGFR ligand expression influence the treatment response of head and neck cancer cell lines.
Jedlinski A; Ansell A; Johansson AC; Roberg K
J Oral Pathol Med; 2013 Jan; 42(1):26-36. PubMed ID: 22643066
[TBL] [Abstract][Full Text] [Related]
35. Targeted therapies and radiation for the treatment of head and neck cancer: are we making progress?
Raben D; Bianco C; Milas L; Ang KK
Semin Radiat Oncol; 2004 Apr; 14(2):139-52. PubMed ID: 15095260
[TBL] [Abstract][Full Text] [Related]
36. The role of the EGFR signaling in tumor microenvironment.
De Luca A; Carotenuto A; Rachiglio A; Gallo M; Maiello MR; Aldinucci D; Pinto A; Normanno N
J Cell Physiol; 2008 Mar; 214(3):559-67. PubMed ID: 17894407
[TBL] [Abstract][Full Text] [Related]
37. Celecoxib induced tumor cell radiosensitization by inhibiting radiation induced nuclear EGFR transport and DNA-repair: a COX-2 independent mechanism.
Dittmann KH; Mayer C; Ohneseit PA; Raju U; Andratschke NH; Milas L; Rodemann HP
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):203-12. PubMed ID: 17996386
[TBL] [Abstract][Full Text] [Related]
38. [Radioresistance parameters in head and neck cancers and methods to radiosensitize].
Biau J; Chautard E; Miroir J; Lapeyre M
Cancer Radiother; 2015 Aug; 19(5):337-46; quiz 360-1, 363. PubMed ID: 26119219
[TBL] [Abstract][Full Text] [Related]
39. [Radiosensitivity and/or radioresistance of head and neck cancers: Biological angle].
Guy JB; Rancoule C; Méry B; Espenel S; Wozny AS; Simonet S; Vallard A; Alphonse G; Ardail D; Rodriguez-Lafrasse C; Magné N
Bull Cancer; 2016 Jan; 103(1):41-7. PubMed ID: 26702507
[TBL] [Abstract][Full Text] [Related]
40. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence.
Barker HE; Paget JT; Khan AA; Harrington KJ
Nat Rev Cancer; 2015 Jul; 15(7):409-25. PubMed ID: 26105538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
